Kukjeon KRX:307750KOSDAQ
국전약품 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days2
Articles tracked1since Sep 11
In Q2 2026, Kukjeon reported revenue of ₩40.5bn, up 21.4% year on year, and operating profit of ₩1.5bn. Kukjeon (국전약품) appeared in 1 Korean news article and 2 DART filings over the past seven days. Coverage peaked on Oct 8 with 1 article.
Filing signals Turnaround Dividend cut Share pledge Screener
Kukjeon quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩40.5bn | +21.4% | ₩1.5bn margin 3.7% | ₩6.1bn |
| Q1 2026 | ₩34.7bn | -9.4% | ₩2.7bn margin 7.7% | −₩2.8bn |
| Q4 2025 derived | ₩30.2bn | -6.0% | ₩136m margin 0.4% | −₩2.5bn |
| Q3 2025 | ₩29.2bn | -6.7% | −₩2.0bn margin −7.0% | −₩2.9bn |
| Q2 2025 | ₩33.3bn | -1.1% | −₩792m margin −2.4% | −₩29m |
| Q1 2025 | ₩38.3bn | -2.6% | ₩113m margin 0.3% | ₩648m |
| Q4 2024 derived | ₩32.1bn | +6.7% | −₩1.7bn margin −5.2% | −₩2.0bn |
| Q3 2024 | ₩31.3bn | +3.9% | −₩2m margin −0.0% | −₩310m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Kukjeon top stories 2 weeks, by number of outlets
- 1